Congress created the 340B drug discount program in 1992 with a simple premise: allow hospitals and federal grantees serving a ...

Last month, a federal court in Maine halted the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program in its tracks — a ...

Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under the False Claims Act (“FCA”). In a recent decision, Adventist Health System v ...

Oregon Health & Science University leaders say a federal drug discount pilot set to begin next year could create a “significant cash-flow risk” for the institution and undermine its ability to serve ...

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have saved patients, taxpayers and employers billions of dollars. But fortunately ...

The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of 340B drugs without the perverse incentives perpetuated by the current ...

Michigan's 340B Drug Pricing Program, meant to help vulnerable patients, is being misused by hospitals, impacting care access.